Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153373 · ClinicalTrials.gov registry record · Phase 2
Dynamic Assessment and Referral System - Evaluation
A Phase 2 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 2
- Development phase
- 758
- Enrollment target
NCT01153373: Completed Phase 2 study, sponsored by University of Massachusetts, Worcester.
NCT01153373 is a Phase 2 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 758 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (470% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153373, a Phase 2 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 758 participants
- Enrollment target
Study Summary
The investigators study will use a randomized controlled design. Eligible and consenting participants will be randomly assigned to one of two conditions: (1) DARSSA Intervention condition, or (2) Minimal Intervention Control condition. All enrolled participants will undergo the DARSSA baseline assessment and will be interviewed immediately following their ED discharge to assess relevant outcomes, such as whether they were asked about substance use and given a referral during their visit. This is referred to as the post-visit interview. All risky substance users enrolled during all phases will be interviewed again at 1- and 3-months post-visit to assess substance use, treatment engagement, and other outcomes. The primary difference between the two conditions is that, for the DARSSA Intervention condition, the subjects will have their reports printed and will be given the option of receiving the dynamic referral, while for the Minimal Intervention Control condition the subjects will undergo the assessment and will receive the standard substance abuse treatment referral list currently in use clinically at each site. The number of assessments and interactions with research staff will remain equal between the two conditions, with the only difference being the active intervention of the DARSSA reports and referrals, and any counseling by healthcare providers this engenders. The remainder of this section describes each phase of the study and enrollment procedures.
Primary Outcome
When comparing the intervention (DARSSA) group to the treatment as usual group, is there an increase in the detected prevalence of tobacco use, alcohol use, and drug abuse.
Interventions
- BEHAVIORAL Self-administered computerized assessment for tobacco, substance abuse, and alcohol use.
- BEHAVIORAL Self-Administered Computerized Assessment and Counseling for Tobacco, Alcohol, and Substance Abuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 758 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
What the finished NCT01153373 record still lists
NCT01153373 is an interventional study that assigns participants to a tested intervention. The registered 758 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (470% higher).
The record links to 0 conditions, and to 2 interventions - of which Self-administered computerized assessment for tobacco, substance abuse, and alcohol use. is the first listed.
NCT01153373 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01153373 about?
NCT01153373 is a clinical study titled "Dynamic Assessment and Referral System - Evaluation". The investigators study will use a randomized controlled design. Eligible and consenting participants will be randomly assigned to one of two conditions: (1) DARSSA Intervention condition, or (2) Minimal Intervention Control condition. All enrolled participants will undergo the DARSSA baseline asses...
What is the current status of trial NCT01153373?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 758 participants. The study started on 2010-06. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01153373?
The interventions under investigation include: Self-administered computerized assessment for tobacco, substance abuse, and alcohol use. (BEHAVIORAL), Self-Administered Computerized Assessment and Counseling for Tobacco, Alcohol, and Substance Abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT01153373?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01153373's enrollment target sits among peer trials
758 43rd of 2000 higher than 1,958 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
- NCT05787821 · 760 participants
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia